Theravance, Inc. (THRX)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
9.810.00 (0.00%)
At close: 4:00 PM EST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.00
Prev Close9.81
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52wk Range
1y Target EstN/A
Market CapN/A
P/E Ratio (ttm)N/A
BetaN/A
Volume0
Avg Vol (3m)N/A
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Associated Press5 months ago

    Innoviva meets 1Q profit forecasts

    On a per-share basis, the South San Francisco, California-based company said it had profit of 4 cents. Earnings, adjusted for amortization costs and stock option expense, were 9 cents per share. The results ...

  • Associated Press8 months ago

    Theravance beats 4Q profit forecasts

    The South San Francisco, California-based company said it had profit of 4 cents per share. The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...

  • Motley Fool8 months ago

    The 3 Most Important Numbers When GlaxoSmithKline Reports Its Fourth-Quarter Results

    GlaxoSmithKline's Q4 report will be out this coming Wednesday, and investors would be wise to keep track of these key figures when GSK's results are released.